{"url":"https://lda.senate.gov/api/v1/filings/7d989835-62aa-4d8a-bf8f-84be3cfaaa5a/","filing_uuid":"7d989835-62aa-4d8a-bf8f-84be3cfaaa5a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2020,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/7d989835-62aa-4d8a-bf8f-84be3cfaaa5a/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Paula M. Short","dt_posted":"2020-07-16T13:19:31.067000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"607 - 14th Street NW","registrant_address_2":"Suite 750","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":320918,"url":"https://lda.senate.gov/api/v1/registrants/320918/","house_registrant_id":39554,"name":"KOUNTOUPES DENHAM CARR & REID, LLC","description":"Federal lobbying and consulting services","address_1":"607 - 14th Street NW","address_2":"Suite 750","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NANCY HARPER MARLOW","contact_telephone":"+1 202-803-4585","dt_updated":"2026-07-22T14:29:32.717701-04:00"},"client":{"id":186710,"url":"https://lda.senate.gov/api/v1/clients/186710/","client_id":1005305,"name":"GLENMARK PHARMACEUTICALS, INC., USA","general_description":"Leading,integrated, research-driven, global pharmaceutical manufacturing company.","client_government_entity":false,"client_self_select":null,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General education about the generic pharmaceutical industry.","foreign_entity_issues":"Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":65235,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":"PAUL","last_name":"PELUSO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59326,"prefix":"ms","prefix_display":"MS.","first_name":"MARY","nickname":null,"middle_name":"R \"RANDI\"","last_name":"REID","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70770,"prefix":null,"prefix_display":null,"first_name":"MJ","nickname":null,"middle_name":null,"last_name":"KENNY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72966,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HECHAVARRIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142331,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"KOUNTOUPES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to Medicaid CPI Penalty.  Issues related to the implementation of H.R. 748, Cornonavirus Aid, Relief, and Economic Security Act (CARES Act), including Medicaid provisions.  Issues related to Medicaid provisions in H.R. 6800, the HEROES Act.","foreign_entity_issues":"Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":65235,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":"PAUL","last_name":"PELUSO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70770,"prefix":null,"prefix_display":null,"first_name":"MJ","nickname":null,"middle_name":null,"last_name":"KENNY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10646,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"HERSHEY","last_name":"CARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72966,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HECHAVARRIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142331,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"KOUNTOUPES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"General information about the company and the industry.  Issues related to affordability and pricing of pharmaceuticals.  Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including drug supply chain dynamics.  H.R. 6800, the HEROES Act. \nIssues related to the federal response to the COVID-19 pandemic.","foreign_entity_issues":"Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":65235,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":"PAUL","last_name":"PELUSO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59326,"prefix":"ms","prefix_display":"MS.","first_name":"MARY","nickname":null,"middle_name":"R \"RANDI\"","last_name":"REID","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70770,"prefix":null,"prefix_display":null,"first_name":"MJ","nickname":null,"middle_name":null,"last_name":"KENNY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72966,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HECHAVARRIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142331,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"KOUNTOUPES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues related to the abuses of the patent system, extensions of drug exclusivity, pay-for-delay, and the inter partes review (IPR) process, including H. R. 1499, the Protecting Consumer Access to Generic Drugs Ace of 2019, and H. R. 938, the BLOCKING Act of 2019. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act).  Issues related to H.R. 6800, the HEROES Act.","foreign_entity_issues":"Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":65235,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":"PAUL","last_name":"PELUSO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59326,"prefix":"ms","prefix_display":"MS.","first_name":"MARY","nickname":null,"middle_name":"R \"RANDI\"","last_name":"REID","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70770,"prefix":null,"prefix_display":null,"first_name":"MJ","nickname":null,"middle_name":null,"last_name":"KENNY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72966,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HECHAVARRIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142331,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"KOUNTOUPES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}